Sciencast Management LP bought a new position in shares of Express Scripts Holding Company (NASDAQ:ESRX) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 8,869 shares of the company’s stock, valued at approximately $566,000.

Other hedge funds have also recently modified their holdings of the company. Nordea Investment Management AB raised its stake in Express Scripts Holding by 1.4% during the second quarter. Nordea Investment Management AB now owns 7,116,445 shares of the company’s stock worth $454,314,000 after purchasing an additional 97,953 shares during the period. First Trust Advisors LP increased its position in shares of Express Scripts Holding by 25.3% during the second quarter. First Trust Advisors LP now owns 708,955 shares of the company’s stock valued at $45,260,000 after acquiring an additional 143,163 shares during the last quarter. Lazard Asset Management LLC increased its position in shares of Express Scripts Holding by 81.8% during the second quarter. Lazard Asset Management LLC now owns 112,666 shares of the company’s stock valued at $7,192,000 after acquiring an additional 50,707 shares during the last quarter. Hancock Holding Co. increased its position in shares of Express Scripts Holding by 9.9% during the first quarter. Hancock Holding Co. now owns 183,489 shares of the company’s stock valued at $12,094,000 after acquiring an additional 16,536 shares during the last quarter. Finally, Twin Capital Management Inc. increased its position in shares of Express Scripts Holding by 0.8% during the first quarter. Twin Capital Management Inc. now owns 46,560 shares of the company’s stock valued at $3,069,000 after acquiring an additional 360 shares during the last quarter. 88.69% of the stock is currently owned by institutional investors.

A number of equities research analysts have weighed in on ESRX shares. ValuEngine cut shares of Express Scripts Holding from a “buy” rating to a “hold” rating in a research report on Friday, September 1st. Robert W. Baird reiterated a “hold” rating and set a $56.00 price target on shares of Express Scripts Holding in a research report on Friday, September 1st. Jefferies Group LLC set a $72.00 price target on shares of Express Scripts Holding and gave the company a “buy” rating in a research report on Tuesday, August 29th. Needham & Company LLC started coverage on shares of Express Scripts Holding in a research report on Friday, July 21st. They set a “hold” rating for the company. Finally, BidaskClub cut shares of Express Scripts Holding from a “hold” rating to a “sell” rating in a research report on Wednesday, July 12th. Six analysts have rated the stock with a sell rating, eleven have given a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $69.09.

In other Express Scripts Holding news, VP Phyllis S. Anderson sold 578 shares of the stock in a transaction that occurred on Friday, September 8th. The shares were sold at an average price of $63.13, for a total value of $36,489.14. Following the completion of the sale, the vice president now owns 10,530 shares of the company’s stock, valued at $664,758.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Everett Neville sold 1,163 shares of the stock in a transaction that occurred on Wednesday, August 23rd. The shares were sold at an average price of $61.48, for a total transaction of $71,501.24. Following the completion of the sale, the vice president now directly owns 18,232 shares of the company’s stock, valued at approximately $1,120,903.36. The disclosure for this sale can be found here. Insiders sold 5,641 shares of company stock valued at $357,317 in the last ninety days. 0.68% of the stock is owned by corporate insiders.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally published by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of US and international copyright laws. The original version of this piece of content can be read at https://www.watchlistnews.com/8869-shares-in-express-scripts-holding-company-esrx-purchased-by-sciencast-management-lp/1636315.html.

Express Scripts Holding Company (NASDAQ:ESRX) opened at 56.81 on Tuesday. The firm’s 50-day moving average is $61.90 and its 200 day moving average is $62.41. Express Scripts Holding Company has a 12-month low of $56.65 and a 12-month high of $77.50. The firm has a market cap of $32.81 billion, a PE ratio of 9.86 and a beta of 0.88.

Express Scripts Holding (NASDAQ:ESRX) last issued its quarterly earnings data on Tuesday, July 25th. The company reported $1.73 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.71 by $0.02. Express Scripts Holding had a net margin of 3.50% and a return on equity of 25.58%. The company had revenue of $25.35 billion during the quarter, compared to the consensus estimate of $25.52 billion. During the same quarter last year, the company earned $1.57 earnings per share. Express Scripts Holding’s revenue for the quarter was up .5% on a year-over-year basis. Equities research analysts predict that Express Scripts Holding Company will post $6.99 EPS for the current year.

Express Scripts Holding Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Institutional Ownership by Quarter for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with Analyst Ratings Network's FREE daily email newsletter.